Navigation Links
Mercy Gynecologic Oncologist Dr. Dwight Im Receives “Patients' Choice” Award
Date:12/10/2009

Gynecologic oncologist Dwight Im, M.D., Director of The Gynecologic Oncology Center at Mercy Medical Center, has been honored by his patients with a Patients’ Choice recognition.

Baltimore, MD (Vocus) December 10, 2009 -- Gynecologic oncologist Dwight Im, M.D., Director of The Gynecologic Oncology Center at Mercy Medical Center, has been honored by his patients with a Patients’ Choice recognition.

Each month, more than 40,000 patients across the U.S. provide online feedback about their experiences with their doctors at http://www.vitals.com. They rate various components such as bedside manner, doctor-patient face time, degree of follow-up, courtesy of office staff and overall opinions. The “Patients’ Choice” award is tabulated by MDx Medical, Inc.

Of those that receive positive reviews, only physicians like Dr. Dwight Im, with near perfect scores, are voted by their patients for this honor. In fact, of the nation’s 720,000 active physicians, less than 5% were accorded this honor by their patients last year.

Notation of this distinction is shared with a number of websites including Vitals.com, RightHealth.com, Google.com and a variety of managed care sites which, in total, are viewed by more than 150,000 people on a daily basis.

A graduate of Princeton University, Dr. Im completed his residency at Johns Hopkins Hospital and fellowship at Hopkins under Neil B. Rosenshein, M.D., Director of nationally acclaimed Weinberg Center for Women’s Health and Medicine at Mercy.

Dr. Im is board certified by the National Board of Medical Examiners and the American Board of Obstetrics and Gynecology. He has made numerous professional presentations on topics such as cervical and ovarian cancer, fallopian tube cancer, vaginal lesions, even breast cancer. Dr. Im has had many clinical articles and chapters published on such subjects as ultrasonic surgical techniques, primary lymphoma of the ovary and other issues relative to reproductive cancers. His interests include pelvic surgery and treating HPV.

Dr. Im serves as a reviewer for Gynecologic Oncology and for Obstetrics and Gynecology.

Mercy Medical Center is a 135-year-old, university affiliated medical facility named one of the top 100 hospitals in the nation and among 10 best centers for women’s health care. For more information about Dr. Dwight Im and Mercy, visit Mercy online at www.mdmercy.com or call 1-800-M.D.-Mercy.

Editor’s Note: To receive a 300 dpi jpg of Dr. Dwight Im, please email request to Dan Collins, Mercy Media Relations, at dcollins(at)mdmercy(dot)com

###

Read the full story at http://www.prweb.com/releases/Mercy-Gynecologic/dwight-im/prweb3325664.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Mercy Primary Care Center Receives $15,000 in Matching Grants for Diabetes Management Program
2. Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option
3. US Airways to Match Miles with Mercy Medical Airlift
4. Mercy Corps Urges Americans to Put the Giving Back Into Thanksgiving
5. Mercy Health Plans Receives Five Star Excellent Rating
6. Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center
7. Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities
8. Mercy Ships Surgeon Addresses Blindness Through Sutureless Technique
9. Katrina Hero, Lt. General Russel Honor (Ret.), to Speak on H1N1 Flu Preparedness at Press Briefing Following AmeriHealth Mercy/PerformRx Conference
10. LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL(TM) Technology
11. Wings of Mercy Benefit Features Miracle on the Hudson Heroes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mercy Gynecologic Oncologist Dr. Dwight Im Receives “Patients' Choice” Award
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: